company background image
TSOI

Therapeutic Solutions International OTCPK:TSOI Stock Report

Last Price

US$0.0058

Market Cap

US$15.4m

7D

-15.9%

1Y

-73.0%

Updated

25 Jan, 2023

Data

Company Financials

Therapeutic Solutions International, Inc.

OTCPK:TSOI Stock Report

Mkt Cap: US$15.4m

TSOI Stock Overview

Therapeutic Solutions International, Inc.

TSOI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

New

Notes are coming soon

Therapeutic Solutions International, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Therapeutic Solutions International
Historical stock prices
Current Share PriceUS$0.0058
52 Week HighUS$0.037
52 Week LowUS$0.0046
Beta1.59
1 Month Change-8.66%
3 Month Change-43.69%
1 Year Change-73.05%
3 Year Change163.64%
5 Year Change-6.45%
Change since IPO-96.00%

Recent News & Updates

Recent updates

Shareholder Returns

TSOIUS PharmaceuticalsUS Market
7D-15.9%-0.4%2.3%
1Y-73.0%7.9%-9.4%

Return vs Industry: TSOI underperformed the US Pharmaceuticals industry which returned 8% over the past year.

Return vs Market: TSOI underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is TSOI's price volatile compared to industry and market?
TSOI volatility
TSOI Average Weekly Movement19.4%
Pharmaceuticals Industry Average Movement11.2%
Market Average Movement7.0%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market2.9%

Stable Share Price: TSOI is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 19% a week.

Volatility Over Time: TSOI's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20074Tim Dixonhttps://www.therapeuticsolutionsint.com

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.

Therapeutic Solutions International, Inc. Fundamentals Summary

How do Therapeutic Solutions International's earnings and revenue compare to its market cap?
TSOI fundamental statistics
Market CapUS$15.41m
Earnings (TTM)-US$4.06m
Revenue (TTM)US$242.35k

63.6x

P/S Ratio

-3.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TSOI income statement (TTM)
RevenueUS$242.35k
Cost of RevenueUS$48.38k
Gross ProfitUS$193.97k
Other ExpensesUS$4.25m
Earnings-US$4.06m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0015
Gross Margin80.04%
Net Profit Margin-1,675.53%
Debt/Equity Ratio60.4%

How did TSOI perform over the long term?

See historical performance and comparison